Abstract:Cardiovascular diseases (CVDs) are a class of disorders affecting the heart or blood vessels. Despite progress in clinical research and therapy, CVDs still represent the leading cause of mortality and morbidity worldwide. The hallmarks of cardiac diseases include heart dysfunction and cardiomyocyte death, inflammation, fibrosis, scar tissue, hyperplasia, hypertrophy, and abnormal ventricular remodeling. The loss of cardiomyocytes is an irreversible process that leads to fibrosis and scar formation, which, in turn, induce heart failure with progressive and dramatic consequences. Both genetic and environmental factors pathologically contribute to the development of CVDs, but the precise causes that trigger cardiac diseases and their progression are still largely unknown. The lack of reliable human model systems for such diseases has hampered the unraveling of the underlying molecular mechanisms and cellular processes involved in heart diseases at their initial stage and during their progression. Over the past decade, significant scientific advances in the field of stem cell biology have literally revolutionized the study of human disease in vitro. Remarkably, the possibility to generate disease-relevant cell types from induced pluripotent stem cells (iPSCs) has developed into an unprecedented and powerful opportunity to achieve the long-standing ambition to investigate human diseases at a cellular level, uncovering their molecular mechanisms, and finally to translate bench discoveries into potential new therapeutic strategies. This review provides an update on previous and current research in the field of iPSC-driven cardiovascular disease modeling, with the aim of underlining the potential of stem-cell biology-based approaches in the elucidation of the pathophysiology of these life-threatening diseases.

Recent advances in iPSC technologies involving cardiovascular and neurodegenerative disease modeling

Human Induced Pluripotent Stem Cell for Modeling Cardiovascular Diseases.

Inducing Pluripotency for Disease Modeling, Drug Development and Craniofacial Applications.

Human-Induced Pluripotent Stem Cell-Based Differentiation of Cardiomyocyte Subtypes for Drug Discovery and Cell Therapy

Induced Pluripotent Stem Cells As a Disease Modeling and Drug Screening Platform

Human-induced Pluripotent Stem Cells As Models for Rare Cardiovascular Diseases: from Evidence-Based Medicine to Precision Medicine

Human Pluripotent Stem Cell-Derived Cardiac Cells: Application in Disease Modeling, Cell Therapy, and Drug Discovery

The Application of Induced Pluripotent Stem Cells in Cardiac Disease Modeling and Drug Testing

Three-Dimensional iPSC-Based In Vitro Cardiac Models for Biomedical and Pharmaceutical Research Applications

Induced pluripotent stem cells for cardiovascular therapeutics: Progress and perspectives

Human pluripotent stem cell models of cardiac disease: from mechanisms to therapies

Modeling Cardiac Disease Mechanisms Using Induced Pluripotent Stem Cell-Derived Cardiomyocytes: Progress, Promises and Challenges

Current Challenges of iPSC-Based Disease Modeling and Therapeutic Implications

iPSC for modeling neurodegenerative disorders

Induced Pluripotent Stem Cells in Drug Discovery and Neurodegenerative Disease Modelling

Modeling neurological disorders by human induced pluripotent stem cells

iPSC-based disease modeling and drug discovery in cardinal neurodegenerative disorders

iPSC-Derived Cardiomyocytes as a Disease Model to Understand the Biology of Congenital Heart Defects

Modeling neurodegenerative diseases with patient-derived induced pluripotent cells: Possibilities and challenges

Pluripotent stem cells for neurodegenerative disease modeling: an expert view on their value to drug discovery

Human Induced Pluripotent Stem Cells for Inherited Cardiovascular Diseases Modeling